NASDAQ : CAMP
Camp4 Therapeutics Corporation — Financial statements
Healthcare · Biotechnology · United States
Last price 3.9 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 244.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Camp4 Therapeutics Corporation (CAMP) reported revenue of 4.22M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 4.22M | 3.50M | 652.00K | 350.00K | |
| Cost of Revenue | 38.69M | 38.20M | 38.82M | 40.62M | 34.09M |
| Gross Profit | -34.47M | -34.70M | -38.16M | -40.27M | -34.09M |
| Selling, General & Admin | 17.91M | 17.36M | 14.92M | 11.61M | 10.23M |
| Research & Development | 676.00K | ||||
| Operating Expenses | 17.91M | 17.36M | 14.92M | 11.61M | 10.91M |
| Operating Income | -52.38M | -52.06M | -53.09M | -51.88M | -45.00M |
| Interest Expense | -33.00K | ||||
| Interest & Investment Income | 2.85M | 2.17M | 1.33M | 2.81M | 904.00K |
| Other Non Operating Income (Expenses) | -57.22M | -30.02M | -33.00K | -187.00K | -95.00K |
| EBT Excluding Unusual Items | -106.75M | -79.91M | -51.79M | -49.29M | -44.19M |
| Asset Writedown | -494.00K | -494.00K | |||
| Pretax Income | -107.24M | -80.40M | -51.79M | -49.29M | -44.19M |
| Net Income | -107.24M | -80.40M | -51.79M | -49.29M | -44.19M |
| Net Income to Common | -107.24M | -80.40M | -51.79M | -49.29M | -44.19M |
| Shares Outstanding (Basic) | 49.27M | 30.38M | 4.69M | 394.98K | 312.30K |
| Shares Outstanding (Diluted) | 49.27M | 30.38M | 4.69M | 394.98K | 312.30K |
| EPS (Basic) | -2.18 | -2.65 | -11.04 | -124.79 | -141.51 |
| EPS (Diluted) | -2.18 | -2.65 | -11.04 | -124.79 | -141.51 |
| Free Cash Flow | -28.72M | -29.83M | -46.00M | -44.83M | -42.57M |
| Free Cash Flow Per Share | -0.58 | -0.98 | -9.81 | -113.51 | -136.31 |
| Operating Margin | -1,242.51% | -1,488.31% | -8,142.33% | -14,822.57% | |
| Profit Margin | -2,543.74% | -2,298.54% | -7,943.40% | -14,083.14% | |
| Free Cash Flow Margin | -681.21% | -852.83% | -7,055.67% | -12,809.43% | |
| EBITDA | -50.56M | -50.42M | -51.39M | -50.20M | -44.12M |
| D&A For EBITDA | 1.82M | 1.64M | 1.70M | 1.68M | 878.00K |
| EBIT | -52.38M | -52.06M | -53.09M | -51.88M | -45.00M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 86.40M | 109.52M | 64.04M | 38.38M | 83.19M |
| Cash & Short-Term Investments | 86.40M | 109.52M | 64.04M | 38.38M | 83.19M |
| Accounts Receivable | 155.00K | ||||
| Other Receivables | 217.00K | 108.00K | 442.00K | 678.00K | |
| Receivables | 217.00K | 155.00K | 108.00K | 442.00K | 678.00K |
| Prepaid Expenses | 214.00K | 559.00K | 591.00K | 361.00K | 158.00K |
| Restricted Cash | 730.00K | 1.35M | |||
| Other Current Assets | 2.47M | 2.52M | 1.65M | 830.00K | 383.00K |
| Total Current Assets | 90.03M | 114.09M | 66.38M | 40.01M | 84.41M |
| Property, Plant & Equipment | 2.44M | 2.74M | 9.87M | 13.31M | 16.79M |
| Other Long-Term Assets | 962.00K | 977.00K | 2.05M | 1.62M | 1.35M |
| Total Assets | 93.43M | 117.81M | 78.31M | 54.95M | 102.55M |
| Accounts Payable | 1.09M | 182.00K | 1.21M | 1.04M | 2.15M |
| Accrued Expenses | 3.18M | 5.54M | 4.30M | 3.01M | 3.17M |
| Current Portion of Long-Term Debt | 27.00K | 176.00K | 405.00K | ||
| Current Portion of Leases | 802.00K | 286.00K | 2.99M | 3.06M | 2.37M |
| Current Unearned Revenue | 13.01M | 9.39M | 385.00K | ||
| Other Current Liabilities | 1.05M | 89.00K | 537.00K | 289.00K | 259.00K |
| Total Current Liabilities | 19.14M | 15.51M | 9.60M | 7.81M | 7.95M |
| Long-Term Debt | 85.00K | ||||
| Long-Term Leases | 1.57M | 1.69M | 5.49M | 8.63M | 10.03M |
| Long-Term Unearned Revenue | 1.50M | 8.11M | |||
| Other Long-Term Liabilities | 71.91M | 44.79M | 72.00K | 2.00K | -38.00K |
| Total Liabilities | 94.12M | 70.10M | 15.16M | 16.53M | 17.93M |
| Common Stock | 6.00K | 6.00K | 2.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 343.32M | 339.85M | 274.89M | 36.23M | 33.14M |
| Retained Earnings | -344.02M | -292.16M | -211.75M | -159.96M | -110.67M |
| Total Common Equity | -693.00K | 47.70M | 63.14M | -123.73M | -77.53M |
| Shareholders' Equity | -693.00K | 47.70M | 63.14M | 38.42M | 84.62M |
| Total Liabilities & Equity | 93.43M | 117.81M | 78.31M | 54.95M | 102.55M |
| Total Debt | 2.37M | 2.00M | 8.66M | 12.18M | 12.39M |
| Net Cash (Debt) | 84.03M | 107.52M | 55.38M | 26.20M | 70.80M |
| Net Cash Per Share | 1.71 | 3.54 | 11.81 | 66.33 | 226.69 |
| Filing Date Shares Outstanding | 62.75M | 51.92M | 20.15M | 460.70K | 312.30K |
| Total Common Shares Outstanding | 51.93M | 51.90M | 20.15M | 460.70K | 312.30K |
| Working Capital | 70.89M | 98.58M | 56.78M | 32.21M | 76.46M |
| Book Value Per Share | -0.01 | 0.92 | 3.13 | -268.57 | -248.26 |
| Tangible Book Value | -693.00K | 47.70M | 63.14M | -123.73M | -77.53M |
| Tangible Book Value Per Share | -0.01 | 0.92 | 3.13 | -268.57 | -248.26 |
| Machinery | 5.67M | 5.57M | 5.57M | 4.78M | 4.17M |
| Leasehold Improvements | 4.52M | 4.52M | 4.52M | 4.52M | 4.52M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -107.24M | -80.40M | -51.79M | -49.29M | -44.19M |
| Depreciation & Amortization | 1.82M | 1.64M | 1.70M | 1.68M | 878.00K |
| Loss (Gain) From Sale of Assets | 258.00K | 258.00K | |||
| Asset Writedown & Restructuring Costs | 583.00K | 494.00K | |||
| Stock-Based Compensation | 5.54M | 4.00M | 4.03M | 2.91M | 1.38M |
| Other Operating Activities | 57.70M | 31.45M | 1.83M | 1.82M | 1.69M |
| Change in Accounts Payable | -102.00K | -1.03M | 168.00K | -1.11M | 1.33M |
| Change in Unearned Revenue | 14.51M | 17.11M | 385.00K | ||
| Change in Other Net Operating Assets | -1.66M | -3.08M | -1.88M | -154.00K | 373.00K |
| Operating Cash Flow | -28.59M | -29.55M | -45.56M | -44.16M | -38.54M |
| Capital Expenditures | -129.00K | -279.00K | -441.00K | -678.00K | -4.03M |
| Sale of Property, Plant & Equipment | 36.00K | 36.00K | |||
| Investing Cash Flow | -93.00K | -243.00K | -441.00K | -678.00K | -4.03M |
| Long-Term Debt Issued | 706.00K | ||||
| Long-Term Debt Repaid | -208.00K | -824.00K | -590.00K | -93.00K | |
| Net Debt Issued (Repaid) | -129.00K | -208.00K | -824.00K | 116.00K | -93.00K |
| Issuance of Common Stock | 57.63M | 57.57M | 76.47M | 185.00K | 55.00K |
| Other Financing Activities | 18.53M | 18.53M | -3.98M | ||
| Financing Cash Flow | 76.03M | 75.89M | 71.66M | 301.00K | 100.16M |
| Net Cash Flow | 47.35M | 46.09M | 25.66M | -44.53M | 57.59M |
| Free Cash Flow | -28.72M | -29.83M | -46.00M | -44.83M | -42.57M |
| Free Cash Flow Margin | -681.21% | -852.83% | -7,055.67% | -12,809.43% | |
| Free Cash Flow Per Share | -0.58 | -0.98 | -9.81 | -113.51 | -136.31 |
| Levered Free Cash Flow | -12.83M | -20.64M | -26.52M | -30.18M | |
| Unlevered Free Cash Flow | -12.83M | -20.64M | -26.52M | -30.16M | |
| Change in Working Capital | 12.75M | 13.01M | -1.33M | -1.27M | 1.70M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 248.50M | 318.03M | 105.08M | ||
| Enterprise Value | 164.48M | 249.12M | 274.34M | ||
| Last Close Price | 3.96 | 6.13 | 5.22 | ||
| PS Ratio | 58.94 | 90.92 | 161.17 | ||
| PB Ratio | 6.67 | 1.66 | |||
| P/TBV Ratio | 6.67 | 1.66 | |||
| EV/Sales Ratio | 39.01 | 71.22 | 420.77 | ||
| Debt / Equity Ratio | -3.42 | 0.04 | 0.14 | 0.32 | 0.15 |
| Net Debt / Equity Ratio | 121.25 | -2.25 | -0.88 | -0.68 | -0.84 |
| Net Debt / EBITDA Ratio | 1.66 | 2.13 | 1.08 | 0.52 | 1.60 |
| Net Debt / FCF Ratio | 2.93 | 3.60 | 1.20 | 0.58 | 1.66 |
| Asset Turnover | 0.06 | 0.04 | 0.01 | 0.00 | |
| Quick Ratio | 4.53 | 7.07 | 6.68 | 4.97 | 10.55 |
| Current Ratio | 4.70 | 7.35 | 6.92 | 5.12 | 10.62 |
| Return on Equity (ROE) | -545.85% | -145.07% | -101.99% | -80.13% | |
| Return on Assets (ROA) | -45.25% | -33.18% | -49.80% | -41.17% | |
| Return on Capital Employed (ROCE) | -70.50% | -50.90% | -77.30% | -110.10% | -47.60% |
| Earnings Yield | -54.97% | -25.28% | -49.29% | ||
| FCF Yield | -11.56% | -9.38% | -43.78% | ||
| Buyback Yield / Dilution | -239.08% | -547.76% | -1,087.44% | -26.47% |